TP53 and colorectal cancer: To investigate the potential role of miR‐5683 in colorectal cancer cells with mutant p53, miR‐5683 mimics or miR‐5683 inhibitors was transfected into cells to overexpress or knock down miR‐5683 (Figures 5G and H and S5D‐F).